Correlation Between Elite Pharma and Nephros
Can any of the company-specific risk be diversified away by investing in both Elite Pharma and Nephros at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Elite Pharma and Nephros into the same portfolio, which is an essential part of the fundamental portfolio management process.
By analyzing existing cross correlation between Elite Pharma and Nephros, you can compare the effects of market volatilities on Elite Pharma and Nephros and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Elite Pharma with a short position of Nephros. Check out your portfolio center. Please also check ongoing floating volatility patterns of Elite Pharma and Nephros.
Diversification Opportunities for Elite Pharma and Nephros
0.0 | Correlation Coefficient |
Pay attention - limited upside
The 3 months correlation between Elite and Nephros is 0.0. Overlapping area represents the amount of risk that can be diversified away by holding Elite Pharma and Nephros in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on Nephros and Elite Pharma is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Elite Pharma are associated (or correlated) with Nephros. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of Nephros has no effect on the direction of Elite Pharma i.e., Elite Pharma and Nephros go up and down completely randomly.
Pair Corralation between Elite Pharma and Nephros
Given the investment horizon of 90 days Elite Pharma is expected to generate 2.42 times more return on investment than Nephros. However, Elite Pharma is 2.42 times more volatile than Nephros. It trades about 0.04 of its potential returns per unit of risk. Nephros is currently generating about 0.04 per unit of risk. If you would invest 4.00 in Elite Pharma on November 2, 2024 and sell it today you would lose (0.27) from holding Elite Pharma or give up 6.75% of portfolio value over 90 days.
| Time Period | 3 Months [change] |
| Direction | Flat |
| Strength | Insignificant |
| Accuracy | 22.67% |
| Values | Daily Returns |
Elite Pharma vs. Nephros
Performance |
| Timeline |
| Elite Pharma |
Risk-Adjusted Performance
0 of 100
Weak | Strong |
Very Weak
| Nephros |
Elite Pharma and Nephros Volatility Contrast
Predicted Return Density |
| Returns |
Pair Trading with Elite Pharma and Nephros
The main advantage of trading using opposite Elite Pharma and Nephros positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Elite Pharma position performs unexpectedly, Nephros can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in Nephros will offset losses from the drop in Nephros' long position.| Elite Pharma vs. Amarantus Bioscience Holdings | Elite Pharma vs. Intelgenx Technologs | Elite Pharma vs. Cytosorbents Crp |
| Nephros vs. Precision Optics, | Nephros vs. Repro Med Systems | Nephros vs. InfuSystems Holdings | Nephros vs. Utah Medical Products |
Check out your portfolio center.Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Share Portfolio module to track or share privately all of your investments from the convenience of any device.
Other Complementary Tools
| Share Portfolio Track or share privately all of your investments from the convenience of any device | |
| Portfolio Center All portfolio management and optimization tools to improve performance of your portfolios | |
| Equity Valuation Check real value of public entities based on technical and fundamental data | |
| Portfolio Volatility Check portfolio volatility and analyze historical return density to properly model market risk | |
| Aroon Oscillator Analyze current equity momentum using Aroon Oscillator and other momentum ratios |